These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38945902)

  • 1. [Resolvin E1 as a potential lead for the treatment of depression].
    Deyama S; Minami M; Kaneda K
    Nihon Yakurigaku Zasshi; 2024; 159(4):210-213. PubMed ID: 38945902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal Administration of Resolvin E1 Produces Antidepressant-Like Effects via BDNF/VEGF-mTORC1 Signaling in the Medial Prefrontal Cortex.
    Deyama S; Aoki S; Sugie R; Fukuda H; Shuto S; Minami M; Kaneda K
    Neurotherapeutics; 2023 Mar; 20(2):484-501. PubMed ID: 36622634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Elucidation of the Mechanisms Underlying the Rapid Antidepressant Actions of Ketamine and Search for Possible Candidates for Novel Rapid-acting Antidepressants].
    Deyama S
    Yakugaku Zasshi; 2023; 143(9):713-720. PubMed ID: 37661437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resolvin E1/E2 ameliorate lipopolysaccharide-induced depression-like behaviors via ChemR23.
    Deyama S; Shimoda K; Suzuki H; Ishikawa Y; Ishimura K; Fukuda H; Hitora-Imamura N; Ide S; Satoh M; Kaneda K; Shuto S; Minami M
    Psychopharmacology (Berl); 2018 Jan; 235(1):329-336. PubMed ID: 29090333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resolvins as potential candidates for the treatment of major depressive disorder.
    Deyama S; Minami M; Kaneda K
    J Pharmacol Sci; 2021 Sep; 147(1):33-39. PubMed ID: 34294370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Resolvins as novel targets for rapid-acting antidepressants].
    Deyama S
    Nihon Yakurigaku Zasshi; 2020; 155(6):381-385. PubMed ID: 33132254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resolution of depression: antidepressant actions of resolvins.
    Deyama S; Kaneda K; Minami M
    Neurosci Res; 2022 Oct; ():. PubMed ID: 36272561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antidepressant-like effect of resolvin E1 in repeated prednisolone-induced depression model mice.
    Aoki S; Deyama S; Sugie R; Ishimura K; Fukuda H; Shuto S; Minami M; Kaneda K
    Behav Brain Res; 2022 Feb; 418():113676. PubMed ID: 34801580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IGF-1 release in the medial prefrontal cortex mediates the rapid and sustained antidepressant-like actions of ketamine.
    Deyama S; Kondo M; Shimada S; Kaneda K
    Transl Psychiatry; 2022 May; 12(1):178. PubMed ID: 35577782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotrophic mechanisms underlying the rapid and sustained antidepressant actions of ketamine.
    Deyama S; Duman RS
    Pharmacol Biochem Behav; 2020 Jan; 188():172837. PubMed ID: 31830487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2
    Fukumoto K; Fogaça MV; Liu RJ; Duman C; Kato T; Li XY; Duman RS
    Proc Natl Acad Sci U S A; 2019 Jan; 116(1):297-302. PubMed ID: 30559184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resolvin D1 and D2 Reverse Lipopolysaccharide-Induced Depression-Like Behaviors Through the mTORC1 Signaling Pathway.
    Deyama S; Ishikawa Y; Yoshikawa K; Shimoda K; Ide S; Satoh M; Minami M
    Int J Neuropsychopharmacol; 2017 Jul; 20(7):575-584. PubMed ID: 28419244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressant-like effects of tomatidine and tomatine, steroidal alkaloids from unripe tomatoes, via activation of mTORC1 in the medial prefrontal cortex in lipopolysaccharide-induced depression model mice.
    Deyama S; Sugie R; Tabata M; Kaneda K
    Nutr Neurosci; 2024 Aug; 27(8):795-808. PubMed ID: 37704369
    [No Abstract]   [Full Text] [Related]  

  • 14. Resolvin E1 Attenuates Chronic Pain-Induced Depression-Like Behavior in Mice: Possible Involvement of Chemerin Receptor ChemR23.
    Suzuki H; Otsuka T; Hitora-Imamura N; Ishimura K; Fukuda H; Fujiwara K; Shuto S; Deyama S; Minami M
    Biol Pharm Bull; 2021; 44(10):1548-1550. PubMed ID: 34602564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resolvin E3 attenuates lipopolysaccharide-induced depression-like behavior in mice.
    Deyama S; Shimoda K; Ikeda H; Fukuda H; Shuto S; Minami M
    J Pharmacol Sci; 2018 Sep; 138(1):86-88. PubMed ID: 30293959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BDNF release and signaling are required for the antidepressant actions of GLYX-13.
    Kato T; Fogaça MV; Deyama S; Li XY; Fukumoto K; Duman RS
    Mol Psychiatry; 2018 Oct; 23(10):2007-2017. PubMed ID: 29203848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medial PFC AMPA receptor and BDNF signaling are required for the rapid and sustained antidepressant-like effects of 5-HT
    Fukumoto K; Fogaça MV; Liu RJ; Duman CH; Li XY; Chaki S; Duman RS
    Neuropsychopharmacology; 2020 Sep; 45(10):1725-1734. PubMed ID: 32396921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotrophic and Antidepressant Actions of Brain-Derived Neurotrophic Factor Require Vascular Endothelial Growth Factor.
    Deyama S; Bang E; Kato T; Li XY; Duman RS
    Biol Psychiatry; 2019 Jul; 86(2):143-152. PubMed ID: 30712809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of neurotrophic and growth factors in the rapid and sustained antidepressant actions of ketamine.
    Deyama S; Kaneda K
    Neuropharmacology; 2023 Feb; 224():109335. PubMed ID: 36403852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AMPA Receptor Activation-Independent Antidepressant Actions of Ketamine Metabolite (S)-Norketamine.
    Yang C; Kobayashi S; Nakao K; Dong C; Han M; Qu Y; Ren Q; Zhang JC; Ma M; Toki H; Yamaguchi JI; Chaki S; Shirayama Y; Nakazawa K; Manabe T; Hashimoto K
    Biol Psychiatry; 2018 Oct; 84(8):591-600. PubMed ID: 29945718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.